{
    "Trade/Device Name(s)": [
        "Synermed ISE Reagents"
    ],
    "Submitter Information": "Infrared Laboratory Systems, LLC (dba Synermed)",
    "510(k) Number": "K181201",
    "Predicate Device Reference 510(k) Number(s)": [
        "K952179"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "JGS",
        "CEM",
        "CGZ"
    ],
    "Summary Letter Date": "July 10, 2018",
    "Summary Letter Received Date": "May 11, 2018",
    "Submission Date": "February 27, 2018",
    "Regulation Number(s)": [
        "21 CFR 862.1665",
        "21 CFR 862.1600",
        "21 CFR 862.1170"
    ],
    "Regulation Name(s)": [
        "Sodium test system",
        "Potassium test system",
        "Chloride test system"
    ],
    "Analyte Class(es)": [
        "chemistry"
    ],
    "Analyte(s)": [
        "Sodium",
        "Potassium",
        "Chloride"
    ],
    "Specimen Type(s)": [
        "Serum"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [
        "Synermed IR-1200"
    ],
    "Method(s)/Technology(ies)": [
        "Ion selective electrode"
    ],
    "Methodologies": [],
    "Submission Type(s)": [
        "Reagent"
    ],
    "Document Summary": "FDA 510(k) summary for Synermed ISE Reagents to quantitatively measure sodium, potassium, and chloride in serum via ion selective electrode method.",
    "Indications for Use Summary": "Intended for in vitro quantitative measurement of sodium, potassium, and chloride in serum; aids diagnosis and treatment of electrolyte and metabolic disorders in clinical laboratories.",
    "fda_folder": "Clinical Chemistry"
}